Research Library

Browse, search, and filter the complete database of verified scientific literature

18 results for “n,n-dimethyltryptamine
Year:
Showing 18 of 180 articles

Filters

Year:
Clinical Trials
NewDOI Resolved

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Stojanović T, Nilsson KW, Fredriksson R et al.
Clinical pharmacology and therapeutics, 2026
Systematic review
Neuroscience
NewDOI Resolved

Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease

Calleja-Conde J, Echeverry-Alzate V, Sanz-SanCristobal M et al.
Experimental neurology, 2026
Cross-sectional survey
Neuroscience
DOI Resolved

Brain-body integromics of the ayahuasca experience

Madrid-Gambin F, Mallaroni P, Haro N et al.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026
Neuroimaging study
Pharmacology
PubMed Verified

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects

Abelo A, Smallridge JW, Von Rotz R et al.
Biomedicine & Pharmacotherapy, 2025
Open Access
Pharmacokinetic modeling
Pharmacology
PubMed Verified

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study

Egger K, Jareno Redondo J, Mueller J et al.
Biomedicine & Pharmacotherapy, 2025
5 citationsOpen Access
Randomized controlled trial
Clinical Trials
PubMed Verified

Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine

Dornbierer DA, Marten L, Mueller J et al.
Frontiers in Pharmacology, 2023
15 citationsOpen Access
First-in-human trial